Tumor vascularity in prostate cancer: an update on circulating endothelial cells and platelets as noninvasive biomarkers

Author： Reeves Fairleigh   Sapre Nikhil   Corcoran Niall   Hovens Christopher  

Publisher： Future Medicine

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.6, 2013-12, pp. : 879-891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of Circulating Tumor Cells in Localized Prostate Cancer

By  

Current Urology, Vol. 7, Iss. 2, 2013-10 ,pp. : 65-69

Karger

Access to resources Recommend Favorite

Circulating tumor cells in prostate cancer: Does (nuclear) size matter?

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3190-3192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Zoledronic Acid Induces a Significant Decrease of Circulating Endothelial Cells and Circulating Endothelial Precursor Cells in the Early Prostate Cancer Neoadjuvant Setting

By  

Oncology, Vol. 85, Iss. 6, 2013-12 ,pp. : 342-347

Karger

Access to resources Recommend Favorite

Circulating nucleic acids as biomarkers of prostate cancer

By Sita-Lumsden Ailsa   Fletcher Claire E   Dart D Alwyn   Brooke Greg N   Waxman Jonathan   Bevan Charlotte L  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 867-877

Future Medicine

Access to resources Recommend Favorite

Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3240-3251

John Wiley & Sons Inc

Access to resources Recommend Favorite